Potentiation by Adrenaline of Ca²⁺ Influx and Mobilization in Stimulated Human Platelets: Dissociation from Thromboxane Generation and Aggregation

Summary

In a medium containing 1 mM extracellular Ca²⁺ (Ca²⁺o), the prior addition of 0.5 pM adrenaline to quin 2-loaded human platelets increased both the rate and amplitude of the rise in cytosolic free Ca2+ (Ca2+i) in response to sub-threshold concentrations of thrombin and PAF and these effects were not prevented by blocking either fibrinogen binding and aggregation or cyclo-oxygenase. In the presence of 2 mM EGTA ([Ca²⁺o] >100 nM), the rate, but not the extent of rise of [Ca²⁺i] was enhanced by adrenaline, and this was also unaffected by blockade of cyclo-oxygenase. Addition of adrenaline 1 min after the other agonist in the presence of 1 mM Ca²⁺o resulted in aggregation without further elevation of [Ca²⁺i]. Adrenaline thus enhances both influx and intracellular mobilization of Ca²⁺ by a mechanism independent of both fibrinogen binding and thromboxane production, but these effects do not fully explain its potentiation of aggregation by other agonists

Keywords

Platelet Ca²⁺ - Adrenaline - Thrombin - PAF - Synergism

• References

• 1 Ardlie NG, Cameron HA, Garrett J. Platelet activation by circulating levels of hormones: a possible link in coronary heart disease. Thromb Res 1984; 36: 315-322
• 2 Mills D CB, Roberts G CK. Effect of adrenaline on human blood platelets. J Physiol (Lond) 1967; 193: 443-453
• 3 Thomas DP. The role of platelet catecholamines in the aggregation of platelets by collagen and thrombin. Exp Biol Med 1968; 3: 129-134
• 4 Steen VM, Holmsen H. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion. Thromb Haemostas 1985; 54: 680-683
• 5 Vargaftig BB, Fouque F, Benveniste J, Odiot J. Adrenaline and PAF- acether synergise to trigger cyclo-oxygenase-independent activation of plasma-free human platelets. Thromb Res 1982; 28: 557-573
• 6 Rao G HR, White JG. Epinephrine potentiation of arachidonate induced aggregation of cyclooxygenase-deficient platelets. Amer J Haematol 1981; 11: 355-66
• 7 Grant JA, Scrutton MC. Positive interaction between agonists in the aggregation response of human blood platelets: interaction between ADP, adrenaline and vasopressin. Brit J Haematol 1980; 44: 109-25
• 8 Thompson NT, Scrutton MC, Wallis RB. Synergistic responses in human platelets. Comparison between aggregation, secretion and cytosolic Ca²⁺ concentrations. Eur J Biochem 1986; 161: 399-408
• 9 Ware JA, Smith M, Salzman EW. Synergism of platelet aggregating agents. Role of evaluation of cytoplasmic calcium. J Clin Invest 1987; 80: 267-271
• 10 Jones D, Fritschy J, Garson J, Nokes TJ C, Kemshead JT, Hardisty RM. A monoclonal antibody binding to human medulloblastoma cells and to the platelet glycoprotein II b-III a complex. Brit J Haematol 1984; 57: 621-631
• 11 Hardisty RM, Powling MJ. Platelet membrane glycoproteins and calcium influx. In: Monoclonal Antibodies and Human Blood Platelets INSERM Symposium No 27 1986; pp 193-200 McGregor JL. (Ed.) Elsevier
• 12 Hallam TJ, Sanchez A, Rink TJ. Stimulus-response coupling in human platelets: changes evoked by PAF in cytoplasmic free Ca²⁺ monitored by Quin 2. Biochem J 1984; 218: 819-827
• 13 Rink TJ, Hallam TJ. What turns platelets on?. Trends Biochem Sci 1984; 9: 215-219
• 14 Ware JA, Johnson PC, Smith M, Salzman EW. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets: measurement with 2-methyl-6-methoxy 8-nitroquinoline (Quin 2) and aequorin. J Clin Invest 1986; 77: 878-886
• 15 Siess W, Weber PC, Lapetina EG. Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change J Biol Chem 1984; 259: 8286-8292
• 16 MacIntyre DE, Pollock WK, Shaw AM, Bushfield M, MacMillan LJ, McNicol A. Agonist induced inositol phospholipid metabolism and Ca²⁺ flux in human platelet activation. Adv Exp Med Biol 1985; 192: 127-144
• 17 Bushfield M, McNicol A, MacIntyre DE. Possible mechanisms of the potentiation of blood-platelet activation by adrenaline. Biochem J 1987; 241: 671-676
• 18 Banga HS, Simons ER, Brass LF, Rittenhouse SE. Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins Ilb/IIIa and dual role of epinephrine. Proc Natl Acad Sci USA 1986; 83: 9197-9201
• 19 Figures WR, Scearce LM, Wachtfogel Y, Chen J, Colman RF, Colman RW. Platelet ADP receptor and a₂-adrenoceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding J Biol Chem 1986; 261: 5981-5986
• 20 Watanabe Y, Horn F, Bauer S, Jakobs KH. Protein kinase C interferes with N_rmediated inhibition of human platelet adenylate cyclase. FEBS letters 1985; 192: 23-27
• 21 MacIntyre DE, McNicol A, Drummond AH. Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca²⁺ flux in human platelets. FEBS Lett 1985; 180: 160-164
• 22 Zavoico GB, Halenda SP, Sha’afi RI, Feinstein MB. Phorbol myristate acetate inhibits thrombin-stimulated Ca²⁺ mobilization and phosphatidyl inositol 4,5-bisphosphate hydrolysis in human platelets. Proc Natl Acad Sci USA 1985; 82: 3859-3862
• 23 Powling MJ, Hardisty RM. Differential effects of 12-0-tetradecanoyl- phorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca²⁺ . Thromb Res 1986; 44: 185-195
• 24 Daniel JL, Dangelmaier CA, Selak M, Smith JB. ADP stimulates IP₃formation in human platelets. FEBS Lett 1986; 206: 299-303